The Intelligence from The Economist The Intelligence from The Economist

Big shot: does a cancer vaccine work?

Aug 27, 2026 · 22m

Summary

The episode covers a breakthrough Moderna mRNA cancer vaccine, Canada’s booming oil industry amid trade tensions, and the death of Dolly Parton. Steve Young shares his experience with a personalized melanoma treatment, while experts discuss its implications. Sarah Larniuk explains how geopolitical factors and new pipelines are driving record profits for Canadian oil producers. Finally, John Fassman reflects on Dolly Parton’s life, career, and legacy following her passing at age 80.

Topics discussed

Intro and episode overview Steve Young's melanoma diagnosis and mRNA vaccine trial How cancer vaccines work and past failures Personalized mRNA vaccine process and future outlook Canadian oil industry boom and record profits Pipeline politics and energy independence strategy Calgary Stampede as an economic barometer Dolly Parton's career, hits, and business savvy Dolly Parton's personal life, faith, and legacy
Listen ad-free on Castria